Quarry LP bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 250 shares of the biotechnology company’s stock, valued at approximately $149,000.
Other hedge funds have also made changes to their positions in the company. New Wave Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth about $40,000. Y.D. More Investments Ltd purchased a new position in Axon Enterprise in the fourth quarter valued at approximately $45,000. Stonebridge Financial Group LLC purchased a new position in Axon Enterprise in the fourth quarter valued at approximately $53,000. GPS Wealth Strategies Group LLC grew its position in shares of Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock worth $56,000 after acquiring an additional 40 shares during the last quarter. Finally, Versant Capital Management Inc grew its position in shares of Axon Enterprise by 4,750.0% during the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock worth $58,000 after acquiring an additional 95 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the company. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Barclays reissued a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Needham & Company LLC restated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, April 23rd. Finally, Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. One analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $626.45.
Axon Enterprise Stock Performance
Axon Enterprise stock opened at $602.46 on Tuesday. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a market capitalization of $46.90 billion, a price-to-earnings ratio of 155.67, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm’s fifty day moving average price is $545.69 and its 200 day moving average price is $573.85.
Insiders Place Their Bets
In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. This represents a 0.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is owned by company insiders.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- How to Buy Gold Stock and Invest in Gold
- Best Defense Stocks in 2025… So Far
- The How And Why of Investing in Oil Stocks
- Alphabet Rebounds After Strong Earnings and Buyback Announcement
- Why Are These Companies Considered Blue Chips?
- Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.